Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.815    0.11 (2.34%)
Bid:
4.755
Ask:
4.80
Spread: 0.045 (0.946%)
Market Cap: £231.10m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Director & Senior Manager Share Awards

28 Apr 2011 13:44

RNS Number : 6633F
Seeing Machines Limited
28 April 2011
 



28 April 2011

 

 

SEEING MACHINES LIMITED

 

DIRECTOR & Senior Manager SHARE AWARDS

Seeing Machines Limited (AIM:SEE), a leading developer of advanced computer based imaging software systems announces that it has today issued 767,099 new fully paid ordinary shares ("New Ordinary Shares") to certain Directors and senior managers under the July 2010 Executive Share Plan which was approved at the Annual General Meeting in November 2010. All shares issued under the plan are based on a salary/fee sacrifice arrangement.

Under the plan the Directors' received shares as follows:

Director

Number of New Ordinary Shares

Holding following receipt of New Ordinary Shares

Percentage holding following receipt of New Ordinary Shares

Robert Charles Sale 1

120,724

5,487,808

1.34%

Nicholas John Cerneaz2

188,631

2,049,044

0.50%

David John Gaul 3

60,362

2,020,948

0.49%

Trent William Victor

60,362

236,236

0.06%

1. Robert Sales shares are 2,745,715 shares held in the name of Caffe Pty Ltd ATF the R C Sale Superannuation Fund, 2,621,369 shares held by Robert's wife Paula Kay Sale and 120,724 shares held in his own name.

2. Nicholas John Cerneaz holds 1,467,332 shares through Cenika Pty Ltd ATF Cenika Super Fund and 581,712 in his own name.

3. David Gaul holds 2,020,948 shares through his company Jaiclimb Pty Limited.

Under the Plan the following senior managers received shares as follows:

Senior Manager

Role

Number of New Ordinary Shares

Holding following receipt of New Ordinary Shares

Percentage holding following receipt of New Ordinary Shares

Belinda Burgess 4

COO & Company Secretary

186,116

2,401,550

0.59%

Timothy Edwards

Principal Engineer

75,452

21,681,316

5.30%

Sebastien Rougeaux

Principal Research Scientist

75,452

22,174,792

5.42%

4. Belinda Burgess holds 965,870 shares in her own name and 1,435,680 shares in the names Belinda Burgess and Jennifer Kruse as trustees for the Meg & Susie Super Fund.

Application has been made for the New Ordinary Shares to be admitted to trading on AIM. It is expected that admission will occur and that dealings will commence at 8.00 a.m. on 6 May 2011. Immediately following admission of the New Ordinary Shares, the Company will have 408,908,546 fully paid ordinary shares on issue.

 

Enquiries:

 

Seeing Machines Limited

Nick Cerneaz, CEO +61 (0) 2 6103 4700

Daniel Stewart & Company plc

Oliver Rigby +44 (0) 20 7776 6550

Walbrook PR Ltd

Bob Huxford +44 (0) 20 7933 8783

Helen Westaway +44 (0) 20 7933 8790

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSDMGZDZRZGMZM
Date   Source Headline
30th Aug 200611:46 amRNSClinical Study Results
14th Aug 200610:57 amRNSGrant Approval
6th Jul 20069:12 amRNSDirector/PDMR Shareholding
29th Jun 20069:37 amRNSEmployee Share Option Scheme
27th Jun 200610:11 amRNSGrant of US Patent
5th Jun 200610:14 amRNSHolding(s) in Company
10th May 20069:27 amRNSHolding(s) in Company
13th Apr 20063:25 pmRNSDirector/PDMR Shareholding
13th Apr 200612:47 pmRNSNew faceLAB Camera Product
10th Apr 20069:19 amRNSMajor Industry Awards Win
15th Mar 20067:01 amRNSInterim Results
3rd Mar 20069:42 amRNSAGM Statement-Amendment
28th Feb 20069:15 amRNSAGM Statement
8th Feb 20069:25 amRNSHolding(s) in Company
31st Jan 20069:30 amRNSHolding(s) in Company
25th Jan 20069:24 amRNSHolding(s) in Company
10th Jan 20069:18 amRNS1st Glaucoma Trial Completion
20th Dec 20053:46 pmRNSIssue of Equity
6th Dec 20059:41 amRNSHolding(s) in Company
1st Dec 20058:53 amRNSAdmission to AIM-Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.